Ozempic’s FDA label warns that pancreatitis has been reported in scientific trials and that individuals who expertise pancreatitis ought to completely cease utilizing the drug.
Nonetheless, knowledgeable consensus now’s that semaglutide and different GLP-1 medication don’t improve the chance of pancreatitis, Drucker stated.
There’s a second downside. GLP-1 medication could cause the discharge of enzymes related to pancreatic illness.
If a affected person tells their physician that they’ve stomach ache (a standard facet impact of GLP-1 medication) and a blood or urine take a look at reveals elevated ranges of amylase or lipase, “that is two of the three standards for pancreatitis,” Drucker says. Nonetheless, if GLP-1 is the plain trigger, an imaging scan of the pancreas shouldn’t be required to verify the prognosis, however could also be essential to rule out different causes.
“We now have rather more information now, and we do not actually see a noticeable improve in pancreatitis with GLP-1 medication,” Drucker says.
Pancreatitis signs
In Ozempic’s official label, the FDA stories that pancreatitis is characterised by “persistent, extreme stomach ache, generally extending to the again, with or with out vomiting.” Different potential signs of pancreatitis embrace fever, speedy coronary heart charge, and fatty or yellow stools.
Acute pancreatitis often develops quickly and often lasts only some days. This illness could require long-term hospitalization. In a small variety of instances, it could actually result in critical penalties, together with demise.
Power pancreatitis, the place signs don’t enhance or maintain coming again, is mostly attributable to alcohol abuse.
